Group One Trading
ACXP icon

Group One Trading’s Acurx Pharmaceuticals ACXP Stock Holding History

Group One Trading’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65
Closed -$2.47K – 7184
2024
Q3 		$2.47K Sell
65
-190
-75% -$8.04K ﹤0.01% 6093
2024
Q2 		$11.5K Sell
255
-145
-36% -$6.38K ﹤0.01% 5572
2024
Q1 		$19.6K Buy
400
+340
+567% +$22.1K ﹤0.01% 5429
2023
Q4 		$4.6K Buy
+60
New +$4.53K ﹤0.01% 6547

Other funds holding ACXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Group One Trading's ACXP Position: Q2 2026 in Review

Group One Trading reduced its Acurx Pharmaceuticals (ACXP) stake by 61% in Q2 2026, selling an estimated $312 and leaving 95 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #7387.

Group One Trading first reported a position in ACXP in Q3 2023 and has held it in 11 quarters since. The position peaked at $33K in Q1 2024. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

  • Group One Trading held 95 shares of Acurx Pharmaceuticals worth $147 as of Q2 2026.
  • Group One Trading sold 150 Acurx Pharmaceuticals shares in Q2 2026, an estimated $312.
  • Acurx Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7387 holding.
  • Group One Trading first reported a position in Acurx Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Group One Trading's Acurx Pharmaceuticals position peaked at $33K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.